Almac Group ltd

Almac Group Ltd. is a globally recognized Contract Development and Manufacturing Organization (CDMO) supporting the full spectrum of drug development services. With over 50 years of experience, Almac provides expert services in R&D, diagnostic solutions, Active Pharmaceutical Ingredient (API) manufacture, formulation development, clinical trial supply, and commercial manufacturing and distribution. Operating from 18 state-of-the-art facilities across Europe, North America, and Asia, Almac employs more than 7,000 skilled professionals dedicated to advancing human health through efficient and high-quality pharmaceutical services. Almac’s capabilities include not only complex R&D and biomarker discovery but also commercialization services that meet regulatory demands and accelerate product launches. The company is trusted by leading global biopharma firms: in the past five years alone, it has contributed to over half of all FDA-approved New Molecular Entities (NMEs) and supports a sizable portion of EU-pre-registered gene therapies. almacgroup.com Driven by a culture of quality, innovation, and client service, Almac invests continuously in expanding its technologies, capacity, and global reach. Its vision is to deliver exceptional solutions across every stage of pharmaceutical product development, ensuring compliance and efficiency while helping partners bring new treatments to patients faster.